- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA. The Symposium will provide an important platform for Merck to engage leading researchers in the nano tech community and create a discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.
Merck places a strong emphasis on innovation in all areas of drug research, development and commercialization. "Merck is pleased to partner with the NSTI in bringing this Symposium to Greater Boston, a leading region for the life sciences industry and advanced patient care," said Dr. Reid Leonard, Merck's Executive Director of Licensing and External Research. "Nanotech 2008 reflects our commitment to innovation and provides an ideal forum for the presentation of siRNA enabling technologies - an area where Merck has assumed a leadership role."
NSTI Nanotech 2008 will be held June 1-5 at the Hynes Convention Center in Boston, MA. Entering its 11th year, Nanotech 2008 is the world's largest and most comprehensive technical and business event in nanotechnology. "Merck's Corporate Symposium will be one of the highlights of next year's conference," noted Dr. Bart Romanowicz, Executive Director of the Nano Science and Technology Institute. "We are delighted that Merck, one of the largest pharmaceutical companies in the world, has partnered with Nanotech 2008 to help address their company's advanced research needs."
To participate in the Merck Corporate Symposium, please submit your abstract through the Nanotech On-Line Abstract Submission form by December 6th, 2007: http://www.nsti.org/Nanotech2008/symposia/Merck.html .
About Nano Science and Technology Institute (NSTI)
The Nano Science and Technology Institute (NSTI; http://www.nsti.org ) is chartered with the advancement and integration of nano and other advanced technologies through education, collaboration and research services. Nanotech 2008 is expected to attract more than 4,000 industrial, academic, business and governmental attendees from around the world.
Merck & Co., Inc. ( http://www.merck.com ) is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
For more information, please click here
The Nano Science and Technology Institute
Jennifer Rocha, 508-357-2925
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Yale researchersí technology turns wasted heat into power June 27th, 2016
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016